Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (2.348)

111

Ritonavir and COVID-19 : pragmatic guidance is important

enthalten in: Lancet (London, England) | 2022

von Waters, L. | Marra, F. | Pozniak, A. | +2

CommentOn: Lancet. 2022 Jan 1;399(10319):21-22. - PMID 34973713

112

In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2

enthalten in: Molecular diversity | 2022

von Abdizadeh, R. | Hadizadeh, F. | Abdizadeh, T.

113

Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients

enthalten in: Clinical pharmacology and therapeutics | 2022

von Stader, F. | Battegay, M. | Sendi, P. | +1

114

Adsorption and desorption of antiviral drugs (ritonavir and lopinavir) on sewage sludges as a potential environmental risk

enthalten in: Journal of hazardous materials | 2022

von Krasucka, P. | Rombel, A. | Yang, X. | +3

115

Repurposing of drugs for COVID-19 : a systematic review and meta-analysis

enthalten in: Panminerva medica | 2022

von Kotecha, P. | Light, A. | Checcucci, E. | +5

116

Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis

enthalten in: Viruses | 2022

von Turvey, S. | Saxinger, L. | Mason, A.

117

Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19 : systematic review and meta-analysis of randomised trials

enthalten in: BMJ open | 2022

von Izcovich, A. | Siemieniuk, R. | Bartoszko, J. | +12

118

Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 2 : Model for the Drug-combination Nanoparticles

enthalten in: Journal of pharmaceutical sciences | 2022

von Perazzolo, S. | Shen, D. | Ho, R.

119

Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates : PETITE Study

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Bekker, A. | Rabie, H. | Salvadori, N. | +12

120

Evaluation of COVID-19 protease and HIV inhibitors interactions

enthalten in: Acta pharmaceutica (Zagreb, Croatia) | 2022

von Tran, L. | Tam, D. | Elhadad, H. | +2